GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Syneos Health Inc (NAS:SYNH) » Definitions » Cyclically Adjusted PS Ratio

Syneos Health (Syneos Health) Cyclically Adjusted PS Ratio : 0.98 (As of May. 26, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Syneos Health Cyclically Adjusted PS Ratio?

As of today (2024-05-26), Syneos Health's current share price is $42.98. Syneos Health's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2023 was $43.90. Syneos Health's Cyclically Adjusted PS Ratio for today is 0.98.

The historical rank and industry rank for Syneos Health's Cyclically Adjusted PS Ratio or its related term are showing as below:

SYNH' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.82   Med: 0.99   Max: 1.38
Current: 1.04

During the past years, Syneos Health's highest Cyclically Adjusted PS Ratio was 1.38. The lowest was 0.82. And the median was 0.99.

SYNH's Cyclically Adjusted PS Ratio is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: 2.38 vs SYNH: 1.04

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Syneos Health's adjusted revenue per share data for the three months ended in Jun. 2023 was $13.092. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $43.90 for the trailing ten years ended in Jun. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Syneos Health Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Syneos Health's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syneos Health Cyclically Adjusted PS Ratio Chart

Syneos Health Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.92

Syneos Health Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1.33 0.92 0.87 1.00

Competitive Comparison of Syneos Health's Cyclically Adjusted PS Ratio

For the Diagnostics & Research subindustry, Syneos Health's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Syneos Health's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Syneos Health's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Syneos Health's Cyclically Adjusted PS Ratio falls into.



Syneos Health Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Syneos Health's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=42.98/43.9
=0.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Syneos Health's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2023 is calculated as:

For example, Syneos Health's adjusted Revenue per Share data for the three months ended in Jun. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2023 (Change)*Current CPI (Jun. 2023)
=13.092/128.7287*128.7287
=13.092

Current CPI (Jun. 2023) = 128.7287.

Syneos Health Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201309 4.926 98.790 6.419
201312 4.838 98.326 6.334
201403 5.141 99.695 6.638
201406 5.476 100.560 7.010
201409 5.687 100.428 7.290
201412 5.698 99.070 7.404
201503 4.895 99.621 6.325
201506 5.578 100.684 7.132
201509 5.958 100.392 7.640
201512 6.934 99.792 8.945
201603 7.395 100.470 9.475
201606 7.127 101.688 9.022
201609 7.051 101.861 8.911
201612 7.392 101.863 9.342
201703 6.928 102.862 8.670
201706 7.072 103.349 8.809
201709 9.436 104.136 11.664
201712 10.317 104.011 12.769
201803 10.122 105.290 12.375
201806 10.312 106.317 12.486
201809 10.823 106.507 13.081
201812 10.563 105.998 12.828
201903 10.826 107.251 12.994
201906 11.132 108.070 13.260
201909 11.208 108.329 13.319
201912 11.511 108.420 13.667
202003 11.012 108.902 13.017
202006 9.631 108.767 11.399
202009 10.408 109.815 12.201
202012 10.815 109.897 12.668
202103 11.462 111.754 13.203
202106 12.213 114.631 13.715
202109 12.867 115.734 14.312
202112 13.080 117.630 14.314
202203 12.798 121.301 13.582
202206 13.202 125.017 13.594
202209 12.947 125.227 13.309
202212 13.175 125.222 13.544
202303 13.131 127.348 13.273
202306 13.092 128.729 13.092

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Syneos Health  (NAS:SYNH) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Syneos Health Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Syneos Health's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Syneos Health (Syneos Health) Business Description

Traded in Other Exchanges
N/A
Address
1030 Sync Street, Morrisville, NC, USA, 27560-5468
Syneos is a global contract research and outsourced commercialization organization that provides services to pharmaceutical and biotechnology firms. Its clinical solutions segment offers early- to late-stage clinical trial support that ranges from specialized staffing models to strategic partnerships that oversee nearly all aspects of a drug program, while the company's commercialization solutions includes outsourced sales, consulting, public relations, and advertising services.
Executives
Michael J. Bonello officer: Chief Financial Officer 4130 PARKLAKE AVENUE, SUITE 400, RALEIGH NY 27612
Stanford Rudnick officer: See remarks C/O SYNEOS HEALTH, INC., 1030 SYNC STREET, MORRISVILLE NC 27560-5468
Christian Tucat officer: Chief Business Officer C/O SYNEOS HEALTH, INC., 1030 SYNC STREET, MORRISVILLE NC 27560-5468
Michael Lee Brooks officer: See remarks C/O SYNEOS HEALTH, INC., 1030 SYNC STREET, MORRISVILLE NC 27560
Jonathan Olefson officer: General Counsel & Corp Secty C/O SYNEOS HEALTH, INC., 1030 SYNC STREET, MORRISVILLE NC 27560
Michelle Keefe officer: Pres., Commercial Solutions C/O SYNEOS HEALTH,INC., 1030 SYNC STREET, MORRISVILLE NC 27560
Jason M. Meggs officer: Chief Financial Officer C/O SYNEOS HEALTH, INC., 1030 SYNC STREET, MORRISVILLE NC 27560
Donna Hildebrand Kralowetz officer: SVP, Chief Accounting Officer C/O SYNEOS HEALTH, INC., 1030 SYNC STREET, MORRISVILLE NC 27560
Matthew E. Monaghan director ONE INVACARE WAY, ELYRIA OH 44035
Alfonso G Zulueta director 4925 INDIANA AVE, LISLE IL 60532
Barbara W. Bodem director C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Linda S Harty director MEDTRONIC PLC, 710 MEDTRONIC PARKWAY NE, LC-150, MINNEAPOLIS MN 55432
Alistair Macdonald officer: Chief Operating Officer C/O SYNEOS HEALTH, INC., 1030 SYNC STREET, MORRISVILLE NC 27560
David S. Wilkes director ONE BAXTER PARKWAY, DEERFIELD IL 60015
Advent International Corp/ma 10 percent owner 800 BOYLSTON STREET SUITE 3300, BOSTON MA 02199

Syneos Health (Syneos Health) Headlines

From GuruFocus